Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study

• Päätekijät: Ekaterina I. Alexeeva (Tekijä), Tatyana M. Dvoryakovskaya (Tekijä), Kseniya B. Isaeva (Tekijä), Tatyana V. Sleptsova (Tekijä), Rina V. Denisova (Tekijä), Margarita A. Soloshenko (Tekijä), Olga L. Lomakina (Tekijä), Anna N. Fetisova (Tekijä), Mariya G. Rudnickaya (Tekijä), Dariya D. Vankova (Tekijä), Yuri M. Dyakonov (Tekijä), Alina A. Alshevskaya (Tekijä), Andrei V. Moskalev (Tekijä), Anna V. Mamutova (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: "Paediatrician" Publishers LLC, 2018-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background. Tumour necrosis factor alpha inhibitors are widely used in the treatment  of juvenile idiopathic arthritis (JIA). To achieve maximum efficiency of genetically engineered biologic drugs, it is necessary to study predictors of the response to therapy. Objective. Our aim was to identify ear...